These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 20627619)

  • 1. Nukacin 3299, a lantibiotic produced by Staphylococcus simulans 3299 identical to nukacin ISK-1.
    Ceotto H; Holo H; da Costa KF; Nascimento Jdos S; Salehian Z; Nes IF; Bastos Mdo C
    Vet Microbiol; 2010 Nov; 146(1-2):124-31. PubMed ID: 20627619
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of a gene cluster of Staphylococcus warneri ISK-1 encoding the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.
    Aso Y; Sashihara T; Nagao J; Kanemasa Y; Koga H; Hashimoto T; Higuchi T; Adachi A; Nomiyama H; Ishizaki A; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2004 Aug; 68(8):1663-71. PubMed ID: 15322349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Description of complete DNA sequence of two plasmids from the nukacin ISK-1 producer, Staphylococcus warneri ISK-1.
    Aso Y; Koga H; Sashihara T; Nagao J; Kanemasa Y; Nakayama J; Sonomoto K
    Plasmid; 2005 Mar; 53(2):164-78. PubMed ID: 15737403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel lantibiotic, nukacin ISK-1, of Staphylococcus warneri ISK-1: cloning of the structural gene and identification of the structure.
    Sashihara T; Kimura H; Higuchi T; Adachi A; Matsusaki H; Sonomoto K; Ishizaki A
    Biosci Biotechnol Biochem; 2000 Nov; 64(11):2420-8. PubMed ID: 11193411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lantibiotic engineering: molecular characterization and exploitation of lantibiotic-synthesizing enzymes for peptide engineering.
    Nagao J; Aso Y; Shioya K; Nakayama J; Sonomoto K
    J Mol Microbiol Biotechnol; 2007; 13(4):235-42. PubMed ID: 17827974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Production of bacteriocins by coagulase-negative staphylococci involved in bovine mastitis.
    dos Santos Nascimento J; Fagundes PC; de Paiva Brito MA; dos Santos KR; do Carmo de Freire Bastos M
    Vet Microbiol; 2005 Mar; 106(1-2):61-71. PubMed ID: 15737474
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heterologous expression and functional analysis of the gene cluster for the biosynthesis of and immunity to the lantibiotic, nukacin ISK-1.
    Aso Y; Nagao J; Koga H; Okuda K; Kanemasa Y; Sashihara T; Nakayama J; Sonomoto K
    J Biosci Bioeng; 2004; 98(6):429-36. PubMed ID: 16233732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel type of immunity protein, NukH, for the lantibiotic nukacin ISK-1 produced by Staphylococcus warneri ISK-1.
    Aso Y; Okuda K; Nagao J; Kanemasa Y; Thi Bich Phuong N; Koga H; Shioya K; Sashihara T; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2005 Jul; 69(7):1403-10. PubMed ID: 16041148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping and identification of the region and secondary structure required for the maturation of the nukacin ISK-1 prepeptide.
    Nagao J; Morinaga Y; Islam MR; Asaduzzaman SM; Aso Y; Nakayama J; Sonomoto K
    Peptides; 2009 Aug; 30(8):1412-20. PubMed ID: 19481127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacteriocin production by Staphylococcus aureus involved in bovine mastitis in Brazil.
    Ceotto H; Nascimento Jdos S; Brito MA; Bastos Mdo C
    Res Microbiol; 2009 Oct; 160(8):592-9. PubMed ID: 19635553
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the nukacin KQU-131, a new type-A(II) lantibiotic produced by Staphylococcus hominis KQU-131 isolated from Thai fermented fish product (Pla-ra).
    Wilaipun P; Zendo T; Okuda K; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2008 Aug; 72(8):2232-5. PubMed ID: 18685189
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of osmotic stress on the production of nukacin ISK-1 from Staphylococcus warneri ISK-1.
    Sashihara T; Dan M; Kimura H; Matsusaki H; Sonomoto K; Ishizaki A
    Appl Microbiol Biotechnol; 2001 Aug; 56(3-4):496-501. PubMed ID: 11549026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Localization and interaction of the biosynthetic proteins for the lantibiotic, Nukacin ISK-1.
    Nagao J; Aso Y; Sashihara T; Shioya K; Adachi A; Nakayama J; Sonomoto K
    Biosci Biotechnol Biochem; 2005 Jul; 69(7):1341-7. PubMed ID: 16041140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular characterisation of aureocin A70, a multi-peptide bacteriocin isolated from Staphylococcus aureus.
    Netz DJ; Sahl HG; Marcelino R; dos Santos Nascimento J; de Oliveira SS; Soares MB; do Carmo de Freire Bastos M
    J Mol Biol; 2001 Aug; 311(5):939-49. PubMed ID: 11531330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ring A of nukacin ISK-1: a lipid II-binding motif for type-A(II) lantibiotic.
    Islam MR; Nishie M; Nagao J; Zendo T; Keller S; Nakayama J; Kohda D; Sahl HG; Sonomoto K
    J Am Chem Soc; 2012 Feb; 134(8):3687-90. PubMed ID: 22329487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of functional domains of lantibiotic-binding immunity protein, NukH, from Staphylococcus warneri ISK-1.
    Okuda K; Aso Y; Nagao J; Shioya K; Kanemasa Y; Nakayama J; Sonomoto K
    FEMS Microbiol Lett; 2005 Sep; 250(1):19-25. PubMed ID: 16009508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibacterial activities of coagulase-negative staphylococci from bovine teat apex skin and their inhibitory effect on mastitis-related pathogens.
    Braem G; Stijlemans B; Van Haken W; De Vliegher S; De Vuyst L; Leroy F
    J Appl Microbiol; 2014 May; 116(5):1084-93. PubMed ID: 24443828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of essential and variable residues of nukacin ISK-1 by NNK scanning.
    Islam MR; Shioya K; Nagao J; Nishie M; Jikuya H; Zendo T; Nakayama J; Sonomoto K
    Mol Microbiol; 2009 Jun; 72(6):1438-47. PubMed ID: 19432794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antimicrobial effect and in vivo preventive and therapeutic effects of partially purified lantibiotic lacticin NK34 against infection by Staphylococcus species isolated from bovine mastitis.
    Kim SY; Shin S; Koo HC; Youn JH; Paik HD; Park YH
    J Dairy Sci; 2010 Aug; 93(8):3610-5. PubMed ID: 20655430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced production of nukacin D13E in Lactococcus lactis NZ9000 by the additional expression of immunity genes.
    Puramattathu TV; Islam MR; Nishie M; Yanagihara S; Nagao J; Okuda K; Zendo T; Nakayama J; Sonomoto K
    Appl Microbiol Biotechnol; 2012 Jan; 93(2):671-8. PubMed ID: 21904816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.